Suggested Topics within your search.
Suggested Topics within your search.
- Pediatric Nursing 2
- Anesthesia 1
- Anesthesiology 1
- Blood 1
- Blood Cell Count 1
- Blood Cells 1
- Blood Cells-Physiology 1
- Cancer 1
- Critical Care Nursing 1
- Critical Illness 1
- Diagnosis, Differential 1
- Diseases 1
- Hematologic Diseases 1
- Hematologic Tests-methods 1
- Hematology 1
- Intraoperative Complications 1
- Medicine 1
- Oncology 1
- Patient Harm 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- Physical therapy 1
- adverse effects 1
- methods 1
- nursing 1
- prevention & control 1
-
1321
-
1322
Ovarian Non-Hodgkin Lymphoma Revealed by Bone Metastasis: A Rare Pediatric Case
Published 2021-01-01Get full text
Article -
1323
Polycythemia with Renal Cell Carcinoma and Normal Erythropoietin Level
Published 2019-01-01“…A 61-year-old obese Caucasian male with past medical history of smoking, hypertension, chronic obstructive pulmonary disease (COPD), and sleep apnea presented to the hematology clinic with polycythemia. Despite the newly-diagnosed polycythemia, the patient denied any significant symptoms or history of blood clots. …”
Get full text
Article -
1324
-
1325
-
1326
-
1327
-
1328
-
1329
-
1330
-
1331
Knockout IL4I1 affects macrophages to improve poor efficacy of CD19 CAR-T combined with PD-1 inhibitor in relapsed/refractory diffuse large B-cell lymphoma
Published 2025-01-01“…Abstract Chimeric antigen receptor (CAR) T-cell therapy plays a critical role in the treatment of B-cell hematologic malignancies. The combination of PD-1 inhibitors and CAR-T has shown encouraging results in treating patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). …”
Get full text
Article -
1332
Racial discrimination among women seeking breast cancer care
Published 2025-01-01Get full text
Article -
1333
-
1334
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report
Published 2023-01-01Get full text
Article -
1335
Systematic Analysis of E3 Ligase-Related Genes Identified UBE2L3 as a Prognostic Biomarker Associated With Drug Resistance in Acute Myeloid Leukemia
Published 2025-01-01“…Chun Ling,1,2 Nengneng Cao,1 Huiping Wang,1 Yang Wan,1 Xue Liang,1 Jinjing Guo,1 Meng Xiao,1 Qiguo Zhang,2 Zhimin Zhai1 1Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230000, People’s Republic of China; 2Department of Hematology, Affiliated Chuzhou Hospital of Anhui Medical University, First People’s Hospital of Chuzhou, Chuzhou, Anhui, 239001, People’s Republic of ChinaCorrespondence: Zhimin Zhai, Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230000, People’s Republic of China, Email zzzm886@163.comBackground: Acute Myeloid Leukemia (AML) is a prevalent neoplastic disorder. …”
Get full text
Article -
1336
-
1337
The origins of the definition of complete remission in acute myeloid leukemia
Published 2025-02-01Get full text
Article -
1338
-
1339
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancer
Published 2025-02-01“…Yet, 49 % of respondents emphasized the need for more real world evidence on CDK4/6i switch safety and efficacy. 96 % of respondents reported discontinuation rates between 0% and 25 % of patients, with constipation and hematological toxicity being the most frequent treatment discontinuation reasons. …”
Get full text
Article -
1340